TrialJAMA dermatology2020

Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials.

Adelaide Hebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.